![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Campbell S, Pearce J M, Hackett G, Cohen-Overbeek T, Hernandez C. Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstetrics and Gynecology 1986; 68: 649–653
- Chappell L C, Seed P T, Briley A L, Kelly F J, Lee R, Hunt B J. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999; 354: 810–816
- Chappell L C, Seed P T, Briley A, Kelly F J, Hunt B J, Charnock-Jones D S. A longitudinal study of biochemical variables in women at risk of preeclampsia. American Journal of Obstetrics and Gynecology 2002; 187: 127–136
- Davey D A, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. American Journal of Obstetrics and Gynecology 1988; 158: 892–898
- Gardosi J, Chang A, Kalyan B, Sahota D, Symonds E M. Customised antenatal growth charts. Lancet 1992; 339: 283–287
- Karatzis E, Lekakis J, Papamichael C, Andreadou I, Cimponeriu A, Aznaouridis K. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. International Journal of Cardiology 2005; 101: 65–70
- Lewis G, Drife J, Botting B, Gordan G, Greer I, Kumar C. Why mothers die. Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1994–1996. Department of Health, Welsh Office, Scottish Office. Department of Health and Social Services. Stationery Office, London 1998
- Madazli R, Kuseyrioglu B, Uzun H, Uludag S, Ocak V. Prediction of preeclampsia with maternal mid-trimester placental growth factor, Activin A, fibronectin and uterine artery velocimetry. International Journal of Gynaecology and Obstetrics 2005; 89: 251–257
- National Heart, Lung, and Blood Institute (NHLBI). 2000, Available at: http://www.nhlbi.nih.gov/health/prof/heart/hbp/hbp_preg.htm
- Papageorgiou A T, Yu C KH, Bindra R, Pandis G, Nicolaides K H. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstetrics and Gynecology 2001; 18: 441–449
- Parra M, Rodrigo R, Barja P, Bosco C, Fernández V, Muñoz H, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. American Journal of Obstetrics and Gynecology 2005; 193: 1486–1491
- Pilalis A, Souka A, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks' gestation. Ultrasound in Obstetrics and Gynecology 2007; 29: 135–140
- Polyzos N P, Mauri D, Tsappi M, Tzioras S, Kamposioras K, Cortinovis I. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: A systematic review. Obstetrical and Gynecological Survey 2007; 62: 202–206
- Poston L, Briley A L, Seed P T, Kelly F J, Shennan A H, Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-control trial. Lancet 2006; 367: 1145–1154
- Sagol S, Ozkinay E, Ozsener S. Impaired antioxidant activity in women with pre-eclampsia. International Journal of Gynecology and Obstetrics 1999; 64: 121–127
- Sharma J B, Mittal S. Oxidative stress and pre-eclampsia. Obstetrics and Gynecology Today 2004; 9: 551–554
- Sharma J B, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress and antioxidant levels in normal pregnancy and pre-eclampsia. International Journal of Gynaecology and Obstetrics 2006; 94: 23–27
- Sikkema J M, van Rijn B B, Franx A, Bruinse H W, de Roos R, Stroes E S. Placental superoxide is increased in pre-eclampsia. Placenta 2001; 22: 304–308